Dr. Grey AI

AOD-9604

Peptide

AOD-9604 is a synthetic peptide fragment of human growth hormone (amino acids 176-191) developed for weight loss. DEVELOPMENT TERMINATED in 2007 after Phase 2b trials showed modest, inconsistent results. C-grade for small weight loss (~2kg over 12 weeks). Despite being abandoned by its developers, it's sold in gray market peptide circles. BANNED by WADA. Not FDA-approved for any use. Animal studies showed better results than human trials.

Quick Answer

What it is

AOD-9604 is a synthetic peptide fragment of human growth hormone (amino acids 176-191) developed for weight loss. DEVELOPMENT TERMINATED in 2007 after Phase 2b trials showed modest, inconsistent results.

Key findings

  • Grade C: Body Weight Reduction
  • Grade C: Fat Mass Reduction (Animal) (Metabolic Health)
  • Grade C: Insulin Sensitivity (Metabolic Health)

Safety

  • No adverse effect on insulin sensitivity
⚠️ Research Notice

This peptide information is for educational and research purposes only. Peptides may not be FDA-approved for human use and may only be legally available for research purposes. Consult qualified healthcare professionals before considering any peptide compounds.

ℹ️ Quick Facts: AOD-9604

Quick Facts: AOD-9604

  • Best Evidence:Grade C
  • Conditions Studied:2
  • Research Outcomes:4
  • Key Effect:Metabolic Health
A0
B0
C3
D1
2 conditions · 4 outcomes

Detailed Outcomes

C
Body Weight Reduction
2.8 kg vs 0.8 kg placebo at 12 weeks (1mg dose); inconsistent across doses
small↓Improves
C
Fat Mass Reduction (Animal)
>50% reduction in weight gain in obese mice
large↓Improves
C
Insulin Sensitivity
No adverse effect on insulin sensitivity
none
D
Cholesterol Profile
Small improvement
small↓Improves